Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis: Complete Statistical AnalysisIndependent statistical analysis of Study of ALXN2050 in Adult Participants With Generalized Myasthenia Gravis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05218096).
- Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries: Complete Statistical AnalysisIndependent statistical analysis of Study of an Implantable Functional Neuromuscular Stimulation System for Patients With Spinal Cord Injuries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3): Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD: Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies: Complete Statistical AnalysisIndependent statistical analysis of Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal Allergies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of an Online Program to Help Parents Talk With Their Tween Children About Health, Gender, Body-Image, and Relationships: Complete Statistical AnalysisIndependent statistical analysis of Study of an Online Program to Help Parents Talk With Their Tween Children About Health, Gender, Body-Image, and Relationships: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02735239).
- Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study of Antimicrobial Activity of Omiganan 1% Gel vs. Chlorhexidine 2% for Topical Skin Antisepsis in Healthy Adult Subjects: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder: Complete Statistical AnalysisIndependent statistical analysis of Study of Aripiprazole (Abilify) Versus Placebo in Children With Subsyndromal Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD): Complete Statistical AnalysisIndependent statistical analysis of Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).: Complete Statistical AnalysisIndependent statistical analysis of Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Arsenic Trioxide in Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Arsenic Trioxide in Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01470248).
- Study of ASTX029 in Subjects With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of ASTX029 in Subjects With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03520075).
- Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.: Complete Statistical AnalysisIndependent statistical analysis of Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery: Complete Statistical AnalysisIndependent statistical analysis of Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson’s Disease Patients With Motor Fluctuations in Korea: Complete Statistical AnalysisIndependent statistical analysis of Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan: Complete Statistical AnalysisIndependent statistical analysis of Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris: Complete Statistical AnalysisIndependent statistical analysis of Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab: Complete Statistical AnalysisIndependent statistical analysis of Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of BGB-A317 in Participants With Previously Treated Unresectable HCC: Complete Statistical AnalysisIndependent statistical analysis of Study of BGB-A317 in Participants With Previously Treated Unresectable HCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03419897).
- Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic: Complete Statistical AnalysisIndependent statistical analysis of Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib: Complete Statistical AnalysisIndependent statistical analysis of Study of BMS-354825 (Dasatinib) in Patients With Chronic Myeloid Leukemia Who Are Either Resistant or Intolerant to Imatinib: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): Complete Statistical AnalysisIndependent statistical analysis of Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04254978).
- Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care: Complete Statistical AnalysisIndependent statistical analysis of Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain: Complete Statistical AnalysisIndependent statistical analysis of Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE): Complete Statistical AnalysisIndependent statistical analysis of Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE): primary endpoint results, effect estimate…
- Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03731364).
- Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations: Complete Statistical AnalysisIndependent statistical analysis of Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II): Complete Statistical AnalysisIndependent statistical analysis of Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.: Complete Statistical AnalysisIndependent statistical analysis of Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.: primary endpoint results, effect estimate…
- Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05285137).
- Study Of Celecoxib In Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Study Of Celecoxib In Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00994461).
- Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis: Complete Statistical AnalysisIndependent statistical analysis of Study Of Celecoxib Or Diclofenac For Efficacy and Safety In Chinese Patients With Ankylosing Spondylitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Cellutome System for Treatment of Individual Lesions in EB Pts: Complete Statistical AnalysisIndependent statistical analysis of Study of Cellutome System for Treatment of Individual Lesions in EB Pts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): Complete Statistical AnalysisIndependent statistical analysis of Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN): primary endpoint results, effect estimate with…
- Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC: Complete Statistical AnalysisIndependent statistical analysis of Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008): Complete Statistical AnalysisIndependent statistical analysis of Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint: Complete Statistical AnalysisIndependent statistical analysis of Study of Cingal® for Symptomatic Relief of Osteoarthritis of Hip Joint: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…